# CHINA PHARMA HOLDINGS, INC. (CPHI) — capital_raise/private_placement [expired]
Source: SEC API (secapi.ai) · situation sit_e11743ca5a11332468b2 · retrieved 2026-08-11T16:12:47.897Z

## Overview
China Pharma Holdings, Inc. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.

China Pharma Holdings Inc. entered into a securities purchase agreement on July 22, 2026 to issue 2,500,000 shares of common stock at $2.00 per share for aggregate gross proceeds of $5,000,000 in a registered direct offering. The closing was expected to occur on or around July 23, 2026. FT Global Capital, Inc. acted as the exclusive placement agent and is entitled to a cash fee equal to 7.0% of the aggregate proceeds received by the Company.

## Terms
- Counterparty: Institutional accredited investor(s) · Deal value: $5.0M · Consideration: cash · Price/share: $2

## Key dates
- Expected close 2026-07-23 · Expired 2026-07-22

## Timeline
- 2026-07-22 · 8-K (0001213900-26-080475): 8-K - CHINA PHARMA HOLDINGS, INC. — *China Pharma Holdings, Inc. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.* China Pharma Holdings Inc. entered into a securities purchase agreement on July 22, 2026 to issue 2,500,000 shares of common stock at $2.00 per share for aggregate gross proceeds of $5,000,000 in a registered direct offering. The closing was expected to occur on or around July 23, 2026. FT Global Capital, Inc. acted as the exclusive placement agent and is entitled to a cash fee equal to 7.0% of the aggregate proceeds received by the Company.
  https://www.sec.gov/Archives/edgar/data/1106644/0001213900-26-080475.txt

## Citations
- 0001213900-26-080475 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026080475